TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

23.50$ +0.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Uniqure NV (QURE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 985 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet QURE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
872 832 770 731 646 557 605 585 888 825 779 985
694 652 596 592 464 390 435 409 716 656 616 834
229 241 243 288 252 159 217 254 597 80 140 413
659 618 556 524 435 368 409 377 694 623 587 810
1.6 4.2 11 7.9 5.3 5.9 2.5 5.6 3.9 5.9 3.6 5.8
16 12 7.7 0.0 0.0 0.0 – – – – – –
76 – – – – – – – – – – –
25 26 26 23 24 22 23 25 25 25 25 25
58 60 59 59 77 71 72 76 74 73 70 62
603 624 623 634 590 563 572 589 660 626 629 661
69 74 63 80 71 40 36 41 101 63 59 83
7.9 8.3 8.0 3.6 11 3.6 3.7 3.9 3.9 3.9 3.0 3.0
5.6 6.6 5.2 4.4 5.4 7.2 5.3 5.5 6.2 5.2 4.4 5.0
101 102 102 103 51 51 52 52 52 50 50 50
269 208 147 97 56 -6.8 34 -4.0 229 199 149 324
-817 -890 -956 -1,012 -1,057 -1,130 -1,174 -1,211 -1,292 -1,329 -1,382 -1,464
48 48 48 49 49 49 53 55 59 58 63 66

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?